Abstract:Objective To investigate the effects of ursolic acid on the proliferation and apoptosis of human HT-29 colon cancer cells. Methods 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and flow cytometry assays were performed to evaluate the effects of ursolic acid on the growth and apoptosis of HT-29 cells. Western blot analysis was applied to investigate the inhibitory effects of ursolic acid on the phosphorylation of the epidermal growth factor receptor (EGFR), extracellular signalregulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38 mitogen-activated protein kinase (p38 MAPK), and the activity of B cell leukemia-2 (Bcl-2), B cell leukemia-xL (Bcl-xL), caspase-3, and caspase-9. Results Ursolic acid inhibited the growth of HT-29 cells in dose- and time-dependent manners. The median inhibition concentration (IC 50 ) values for 24, 48, and 72 h treatment were 26, 20, and 18 μmol/L, respectively. The apoptotic rates of 10, 20, and 40 μmol/L ursolic acid treatments for 24 h were 5.74%, 14.49%, and 33.05%, and for 48 h were 9%, 21.39%, and 40.49%, respectively. Ursolic acid suppressed the phosphorylation of EGFR, ERK1/2, p38 MAPK, and JNK, which is well correlated with its growth inhibitory effect. 10, 20, and 40 μmol/L ursolic acid significantly inhibited the proliferation of EGF-stimulated HT-29 cells ( P <0.05). Cell proliferation was most significantly inhibited when treated with 10 and 20 μmol/L ursolic acid combined with 200 nmol/L AG 1478 or 10 μmol/L U0126 ( P <0.01). Besides, it also down-regulated the expression of Bcl-2 and Bcl-xL and activated caspase-3 and caspase-9. Conclusion Ursolic acid induces apoptosis in HT-29 cells by suppressing the EGFR/MAPK pathway, suggesting that it may be a potent agent for the treatment of colorectal cancer.

The Cytotoxic Activity of Ursolic Acid Derivatives.

Synthesis and Evaluation of Ursolic Acid Derivatives As Potent Cytotoxic Agents.

The Synthesis of Ursolic Acid Derivatives with Cytotoxic Activity and the Investigation of Their Preliminary Mechanism of Action.

Synthesis and Antitumor Activity Evaluation of Novel Ursolic Acid Derivatives

In Vitro and in Vivo Anticancer Activity Evaluation of Ursolic Acid Derivatives

Synthesis and Anti-Tumor Activity of Derivatives of Ring A of Ursolic Acid

Synthesis and cytotoxicity of novel ursolic acid derivatives containing an acyl piperazine moiety.

Synthesis and evaluation as potential antitumor agents of novel ursolic acid derivatives

Synthesis, Characterization and Cytotoxic Activity of Novel Oleanolic Acid and Ursolic Acid Derivatives

Synthesis and Biological Evaluation of Novel Ursolic acid Derivatives as Potential Anticancer Prodrugs

Synthesis of [3Β-Acetoxy-urs-12-en-28-oyl]-1-monoglyceride and Investigation on Its Anti Tumor Effects Against BGC-823.

Synthesis and Anti-angiogenesis Activities of Ursolic Acid Derivatives

ChemInform Abstract: in Vitro and in Vivo Anticancer Activity Evaluation of Ursolic Acid Derivatives.

Synthesis and antitumor activity of novel quinoline derivatives of ursolic acid

Design, Synthesis, and Biological Evaluation of Novel Nitrogen Heterocycle-Containing Ursolic Acid Analogs as Antitumor Agents

Synthesis, Biological Activity, ADME and Molecular Docking Studies of Novel Ursolic Acid Derivatives as Potent Anticancer Agents

Synthesis and Cytotoxicity Evaluation of Oleanolic Acid Derivatives

Synthesis of Amino Acid-Modified Ursolic Acid Derivatives and Their Antitumor Activity Against Gastric Carcinoma

Ursolic Acid Inhibits Proliferation and Induces Apoptosis of HT-29 Colon Cancer Cells by Inhibiting the EGFR/MAPK Pathway.

Ursolic acid: a pentacyclic triterpenoid that exhibits anticancer therapeutic potential by modulating multiple oncogenic targets.

Synthesis, characterization and in vitro anti-proliferative effects of pentacyclic triterpenoids